Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 20;24(1):398.
doi: 10.1186/s12890-024-03098-3.

Effect of antigen removal in hypersensitivity pneumonitis

Affiliations

Effect of antigen removal in hypersensitivity pneumonitis

Mark J Robertshaw et al. BMC Pulm Med. .

Abstract

Background: Antigen removal is a cornerstone of treatment of hypersensitivity pneumonitis (HP), but its association with transplant-free survival remains unclear. Further, HP guidelines conflict as to whether antigen removal is a recommended diagnostic test in patients with suspected HP.

Objective: The purpose of this study is to (1) evaluate the impact of antigen removal on transplant-free survival and (2) to describe the impact of antigen removal on pulmonary function testing and imaging in a retrospective cohort of patients with HP.

Methods: We retrospectively identified HP patients evaluated between 2011 and 2020. Demographic, physiologic, radiographic, and pathologic data were recorded.

Results: 212 patients were included in the cohort. Patients who identified and removed antigen had a better transplant-free survival than patients who did not identify antigen and patients who identified but did not remove antigen. Antigen removal was associated with improvement in FVC by 10% predicted in 16.9% of patients with fibrotic HP and 56.7% of patients with nonfibrotic HP.

Discussion: Our results suggest that over 50% of nonfibrotic HP patients and 16.9% of fibrotic HP patients improve with exposure removal. In addition, antigen removal, rather than antigen identification, is associated with transplant-free survival in HP.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report.

Figures

Fig. 1
Fig. 1
Flow chart for HP diagnosis in the cohort
Fig. 2
Fig. 2
Direct adjusted survivor functions comparing groups (1) antigen identified and removed; (2) antigen identified but not removed; and (3) antigen not identified
Fig. 3
Fig. 3
Direct adjusted survivor functions comparing groups based on known antigen removal: antigen identified but not removed or antigen not identified vs. antigen identified and removed
Fig. 4
Fig. 4
Proportion of patients with > 10% improvement in FVC following antigen removal based on degree of fibrosis on HRCT

References

    1. Fernandez Perez ER, Travis WD, Lynch DA, et al. Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST Guideline and Expert Panel Report. Chest. 2021;160(2):e97–156. 10.1016/j.chest.2021.03.066 - DOI - PubMed
    1. Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(3):e36–69. 10.1164/rccm.202005-2032ST - DOI - PMC - PubMed
    1. Fernandez Perez ER, Swigris JJ, Forssen AV, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144(5):1644–51. 10.1378/chest.12-2685 - DOI - PMC - PubMed
    1. Kypreos M, Batra K, Glazer CS, Adams TN. Impact of number and type of identified antigen on transplant-free survival in hypersensitivity pneumonitis. PLoS ONE. 2022;17(9):e0273544. 10.1371/journal.pone.0273544 - DOI - PMC - PubMed
    1. Adams TN, Newton CA, Glazer CS. Role of Antigen Type in Survival in Chronic Hypersensitivity Pneumonitis. Lung. 2019;197(1):113–4. 10.1007/s00408-018-0187-6 - DOI - PMC - PubMed

LinkOut - more resources